Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
eFFECTOR Therapeutics, Inc. - Common Stock
(NQ:
EFTR
)
0.1800
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jul 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about eFFECTOR Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Why AeroClean Technologies Is Trading Higher By Over 39%; Here Are 26 Stocks Moving Premarket
↗
October 04, 2022
Gainers Bit Brother Limited (NASDAQ: BTB) rose 91.7% to $0.2150 in pre-market trading after declining around 14% on Monday.
Via
Benzinga
Aspen Group And 2 Other Stocks Under $2 Insiders Are Aggressively Buying
↗
September 28, 2022
U.S. oil futures traded higher this morning on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
September 28, 2022
Gainers Acumen Pharmaceuticals (NASDAQ:ABOS) shares increased by 80.8% to $8.5 during Wednesday's pre-market session. The company's market cap stands at $344.2 million.
Via
Benzinga
5 Value Stocks To Watch In The Healthcare Sector
↗
September 26, 2022
What is a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators...
Via
Benzinga
eFFECTOR's Cancer Therapy Achieves Two Partial Responses In Early-Stage Study
↗
June 06, 2022
Via
Benzinga
Analyst Ratings For eFFECTOR Therapeutics
↗
January 25, 2022
Analysts have provided the following ratings for eFFECTOR Therapeutics (NASDAQ:...
Via
Benzinga
Important Biotech Catalysts For September 14, 2022 - End Of The Day Summary
↗
September 14, 2022
Via
Benzinga
Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday
↗
September 12, 2022
Gainers Digital Media Solutions, Inc. (NYSE: DMS) shares climbed 71.9% to close at $2.20 on Friday after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
September 02, 2022
Via
Benzinga
Why Is Turquoise Hill Resources Down By 18%: Here Are 31 Stocks Moving Premarket
↗
August 15, 2022
Gainers Plus Therapeutics, Inc. (NASDAQ: PSTV) shares rose 31.2% to $0.6931 in pre-market trading as the company presented positive data from ongoing ReSPECT™ clinical trials at the Annual Conference...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
August 09, 2022
Via
Benzinga
Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday
↗
August 10, 2022
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method.
Via
Benzinga
Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session
↗
August 09, 2022
Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD....
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
↗
July 27, 2022
Wednesday saw 83 companies set new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
July 20, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
↗
July 25, 2022
On Monday, 100 companies reached new 52-week lows.
Via
Benzinga
5 Value Stocks In The Healthcare Sector
↗
July 18, 2022
What is a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators...
Via
Benzinga
4 Stocks Under $2 Insiders Are Aggressively Buying: NEXGEL, eFFECTOR Therapeutics And More
↗
June 28, 2022
U.S. crude oil futures traded higher by over 1% on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...
Via
Benzinga
5 Value Stocks To Watch In The Healthcare Sector
↗
April 18, 2022
What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...
Via
Benzinga
Analyst Ratings For eFFECTOR Therapeutics
↗
March 17, 2022
Over the past 3 months, 4 analysts have published their opinion on eFFECTOR Therapeutics (NASDAQ:EFTR) stock. These analysts are typically employed by large Wall Street banks and...
Via
Benzinga
eFFECTOR Therapeutics's Return On Capital Employed Overview
↗
March 17, 2022
According to Benzinga Pro, during Q4, eFFECTOR Therapeutics (NASDAQ:EFTR) earned $19.05 million, a 114.54% increase from the preceding quarter. eFFECTOR Therapeutics's sales...
Via
Benzinga
83 Biggest Movers From Yesterday
↗
June 09, 2022
Gainers Symbotic Inc. (NASDAQ: SYM) shares surged 120.6% to settle at $20.07 on Wednesday. Symbotic reported the completion of its business combination with SVF Investment Corp. to become a publicly...
Via
Benzinga
50 Stocks Moving In Wednesday's Mid-Day Session
↗
June 08, 2022
Gainers HeartCore Enterprises, Inc. (NASDAQ: HTCR) shares gained 81% to $1.8503 after the company authorized a $3.5 million buyback.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
↗
January 26, 2022
During Wednesday's morning session, 34 stocks hit new 52-week lows. Things to Consider About Today's 52-Week Lows: Illumina (NASDAQ:ILMN) was the biggest company...
Via
Benzinga
95 Biggest Movers From Yesterday
↗
June 07, 2022
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) shares gained 100.4% to close at $4.75 on Monday after the FDA granted clearance for the company's pūrgo technology, classifying it as a class II...
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
↗
February 15, 2022
Tuesday's session saw 95 companies set new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: The largest company by market cap to set a new 52-...
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
↗
February 08, 2022
Tuesday's session saw 109 companies set new 52-week lows. Interesting Points From Today's 52-Week Highs And Lows: The largest company in terms of market cap...
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
↗
January 25, 2022
On Tuesday, 88 companies set new 52-week lows. Interesting Highlights From Today's 52-Week Lows: Credit Suisse Group (NYSE:CS) was the largest, in terms of market cap...
Via
Benzinga
10 Biggest Price Target Changes For Tuesday
↗
January 25, 2022
Needham cut Medtronic plc (NYSE:MDT) price target f...
Via
Benzinga
eFFECTOR Secures $50M Funding From Lincoln Park Capital
↗
January 25, 2022
eFFECTOR Therapeutics Inc (NASDAQ: EFTR) entered into an investment agreement with Lincoln Park Capital for up to $50 million over 36 months. The Company said...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today